Global Information
회사소개 | 문의 | 비교리스트

세계의 골관절염 시장(IA 주사제, NSAIDs, 진통제) : 인사이트, 동향 및 예측(2022-2026년)

Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)

리서치사 Koncept Analytics
발행일 2022년 05월 상품코드 1072725
페이지 정보 영문 95 Pages 배송안내
가격
US $ 1,600 ₩ 2,034,000 PDF (Single User License)
US $ 2,000 ₩ 2,543,000 PDF (Corporate User License)


세계의 골관절염 시장(IA 주사제, NSAIDs, 진통제) : 인사이트, 동향 및 예측(2022-2026년) Global Osteoarthritis Market (IA Injections, NSAIDs & Analgesics): Insights, Trends & Forecast (2022-2026)
발행일 : 2022년 05월 페이지 정보 : 영문 95 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 골관절염 시장 규모는 예측기간 중 9.84%의 CAGR로 확대되고, 2026년에는 매출로 121억 4,000만 달러 규모로 성장할 것으로 예측됩니다.

골관절염 발생률 증가, 노년 인구 증가, 1인당 의료비 증가, 비만 인구 증가, 소비자신뢰지수 개선 등의 요인이 시장 성장 원동력이 될 것으로 예상됩니다. 한편, 비지니스상 위험, 환자의 건강과 관련된 위험, 엄격한 규제 등이 시장 성장에 영향을 미칠 것으로 생각됩니다.

지역별로는 북미 지역이 가장 높은 성장률을 나타내고 있습니다. 노년 인구 증가, HA 주사 수요 급증, 스포츠 부상 증가, E-Commerce 산업의 발전 등이 이 성장을 지지하고 있습니다.

세계의 골관절염(Osteoarthritis) 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모 추정과 예측, 각종 부문·지역/주요 국가별 내역, 주요 기업 개요 등을 정리했습니다.

목차

제1장 시장 개요

  • 원인
  • 증상
  • 진단
  • 치료

제2장 세계의 골관절염 시장 분석

  • 세계의 골관절염 시장 규모
  • 세계의 골관절염 시장 규모 예측
  • 세계의 골관절염 시장 규모와 예측 : 부위별
    • 슬관절 골관절염
    • 슬관절 골관절염 : 지역별
  • 세계의 골관절염 시장 규모와 예측 : 치료 종류별
    • IA 주사제
    • 골관절염 치료제
    • 골관절염 치료제 : 종류별
    • NSAIDs
    • 진통제
    • 골관절염 치료제 : 투여 경로별
    • 비경구약
    • 경구약
  • 세계의 골관절염 시장 규모와 예측 : 유통 경로별
  • 세계의 골관절염 시장 규모와 예측 : 지역별

제3장 골관절염 시장 분석 : 지역별

  • 북미
  • 유럽
  • 아시아태평양

제4장 시장 역학

  • 성장 촉진요인
  • 주요 동향·전개
  • 과제

제5장 기업 개요

  • Johnson & Johnson
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi S.A.
KSM 22.05.13

List of Figures

  • Global Osteoarthritis Market Value (2017-2021)
  • Global Osteoarthritis Market Value Forecast (2022-2026)
  • Global Osteoarthritis Market Value by Anatomy Type (2021)
  • Global Knee Osteoarthritis Market Value (2017-2021)
  • Global Knee Osteoarthritis Market Value Forecast (2022-2026)
  • Global Knee Osteoarthritis Market Value by Region (2021)
  • Global Osteoarthritis Market Value by Treatment Type (2021)
  • Global Osteoarthritis IA Injections Market Value (2017-2021)
  • Global Osteoarthritis IA Injections Market Value Forecast (2022-2026)
  • Global Osteoarthritis Drugs Market Value (2017-2021)
  • Global Osteoarthritis Drugs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Drugs Market Value by Type (2021)
  • Global Osteoarthritis NSAIDs Market Value (2017-2021)
  • Global Osteoarthritis NSAIDs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Analgesics Market Value (2017-2021)
  • Global Osteoarthritis Analgesics Market Value Forecast (2022-2026)
  • Global Osteoarthritis Drugs Market Value by Route of Administration (2021)
  • Global Osteoarthritis Parenteral Drugs Market Value (2017-2021)
  • Global Osteoarthritis Parenteral Drugs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Oral Drugs Market Value (2017-2021)
  • Global Osteoarthritis Oral Drugs Market Value Forecast (2022-2026)
  • Global Osteoarthritis Market Value by Distribution Channels (2020)
  • Global Osteoarthritis Market Value by Region (2021)
  • North America Osteoarthritis Market Value (2017-2021)
  • North America Osteoarthritis Market Value Forecast (2022-2026)
  • North America Osteoarthritis Market Value by Anatomy Type (2021)
  • North America Knee Osteoarthritis Market Value (2017-2021)
  • North America Osteoarthritis Market Value Forecast (2022-2026)
  • North America Osteoarthritis Market Value by Country (2020)
  • The U.S. Osteoarthritis Market Value (2017-2021)
  • The U.S. Osteoarthritis Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Market Value by Treatment Type (2021)
  • The U.S. Osteoarthritis IA Injections Market Value (2017-2021)
  • The U.S. Osteoarthritis IA Injections Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Drugs Market Value (2017-2021)
  • The U.S. Osteoarthritis Drugs Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Drugs Market Value by Type (2021)
  • The U.S. Osteoarthritis NSAIDs Market Value (2017-2021)
  • The U.S. Osteoarthritis NSAIDs Market Value Forecast (2022-2026)
  • The U.S. Osteoarthritis Analgesics Market Value (2017-2021)
  • The U.S. Osteoarthritis Analgesics Market Value Forecast (2022-2026)
  • Europe Osteoarthritis Market Value (2017-2021)
  • Europe Osteoarthritis Market Value Forecast (2022-2026)
  • Europe Osteoarthritis Market Value by Anatomy Type (2021)
  • Europe Knee Osteoarthritis Market Value (2017-2021)
  • Europe Knee Osteoarthritis Market Value Forecast (2022-2026)
  • Asia-Pacific Osteoarthritis Market Value (2017-2021)
  • Asia-Pacific Osteoarthritis Market Value Forecast (2022-2026)
  • Asia-Pacific Osteoarthritis Market Value by Anatomy Type (2021)
  • Asia-Pacific Knee Osteoarthritis Market Value (2017-2021)
  • Asia-Pacific Knee Osteoarthritis Market Value Forecast (2022-2026)
  • Global Osteoarthritis Population (2017-2021)
  • Global Geriatric Population (2017-2021)
  • Global Healthcare Expenditure per Capita (2017-2021)
  • The U.S. Obese Population (2017-2021)
  • Consumer Confidence Index in US and Europe (2017-2021)
  • Global Pharmaceutical R&D Expenditures (2017-2021)
  • Global Online Pharmaceutical Sales (2022-2026)

The global osteoarthritis market revenues are forecasted to touch US$12.14 billion in 2026, growing at a CAGR of 9.84% for the period spanning 2022 to 2026.

Factors such as increasing occurrence of osteoarthritis, growing geriatric population, rising healthcare expenditure per capita, growing obese population and improving consumer confidence index are expected to drive the market growth. However, growth of the industry would be challenged by associated business risk, patient health-associated risk and stringent regulations. A few notable trends include growth in pharmaceutical R&D expenditures, progressing product pipeline, advancement in osteoarthritis treatments and growth in online pharmaceutical sales.

The global osteoarthritis market by treatment type is segmented into categories i.e. IA Injections (corticosteroids and HA) and Drugs (NSAIDs & Analgesics). Among them, IA injections held the largest share of the industry revenues due to growth in prevalence of joint disorders across the world.

The fastest growing regional market is North America. The growth was supported by growth in geriatric population, surge in HA injections demand, rise in sports injuries and development in e-commerce industry. The U.S. is the largest market and is already well-penetrated at developed market levels.

Scope of the report:

  • The report provides a comprehensive analysis of the global osteoarthritis market, segmented into IA Injections and Drugs (Analgesics and NSAIDs).
  • The major regional markets (North America, Europe and Asia-Pacific) have been analysed along with country coverage of US.
  • The market dynamics such as growth drivers, market trends and challenges are analysed in-depth.
  • The company profiles of leading players i.e. Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline Plc, Pfizer Inc. and Sanofi S.A. are also presented in detail.

Key Target Audience:

  • Osteoarthritis Therapeutics Manufacturers
  • Ingredient Suppliers
  • End Users
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Causes
  • 1.3 Symptoms
  • 1.4 Diagnosis
  • 1.5 Treatment

2. Global Osteoarthritis Market Analysis

  • 2.1 Global Osteoarthritis Market Value
  • 2.2 Global Osteoarthritis Market Value Forecast
  • 2.3 Global Osteoarthritis Market Value by Anatomy Type
    • 2.3.1 Global Knee Osteoarthritis Market Value
    • 2.3.2 Global Knee Osteoarthritis Market Value Forecast
    • 2.3.3 Global Knee Osteoarthritis Market Value by Region
  • 2.4 Global Osteoarthritis Market Value by Treatment Type
    • 2.4.1 Global Osteoarthritis IA Injections Market Value
    • 2.4.2 Global Osteoarthritis IA Injections Market Value Forecast
    • 2.4.3 Global Osteoarthritis Drugs Market Value
    • 2.4.4 Global Osteoarthritis Drugs Market Value Forecast
    • 2.4.5 Global Osteoarthritis Drugs Market Value by Type
    • 2.4.6 Global Osteoarthritis NSAIDs Market Value
    • 2.4.7 Global Osteoarthritis NSAIDs Market Value Forecast
    • 2.4.8 Global Osteoarthritis Analgesics Market Value
    • 2.4.9 Global Osteoarthritis Analgesics Market Value Forecast
    • 2.4.10 Global Osteoarthritis Drugs Market Value by Route of Administration
    • 2.4.11 Global Osteoarthritis Parenteral Drugs Market Value
    • 2.4.12 Global Osteoarthritis Parenteral Drugs Market Value Forecast
    • 2.4.13 Global Osteoarthritis Oral Drugs Market Value
    • 2.4.14 Global Osteoarthritis Oral Drugs Market Value Forecast
  • 2.5 Global Osteoarthritis Market Value by Distribution Channels
  • 2.6 Global Osteoarthritis Market Value by Region

3. Regional Osteoarthritis Market Analysis

  • 3.1 North America
    • 3.1.1 North America Osteoarthritis Market Value
    • 3.1.2 North America Osteoarthritis Market Value Forecast
    • 3.1.3 North America Osteoarthritis Market Value by Anatomy Type
    • 3.1.4 North America Knee Osteoarthritis Market Value
    • 3.1.5 North America Knee Osteoarthritis Market Value Forecast
    • 3.1.6 North America Osteoarthritis Market Value by Country
    • 3.1.7 The U.S. Osteoarthritis Market Value
    • 3.1.8 The U.S. Osteoarthritis Market Value Forecast
    • 3.1.9 The U.S. Osteoarthritis Market Value by Treatment Type
    • 3.1.10 The U.S. Osteoarthritis IA Injections Market Value
    • 3.1.11 The U.S. Osteoarthritis IA Injections Market Value Forecast
    • 3.1.12 The U.S. Osteoarthritis Drugs Market Value
    • 3.1.13 The U.S. Osteoarthritis Drugs Market Value Forecast
    • 3.1.14 The U.S. Osteoarthritis Drugs Market Value by Type
    • 3.1.15 The U.S. Osteoarthritis NSAIDs Market Value
    • 3.1.16 The U.S. Osteoarthritis NSAIDs Market Value Forecast
    • 3.1.17 The U.S. Osteoarthritis Analgesics Market Value
    • 3.1.18 The U.S. Osteoarthritis Analgesics Market Value Forecast
  • 3.2 Europe
    • 3.2.1 Europe Osteoarthritis Market Value
    • 3.2.2 Europe Osteoarthritis Market Value Forecast
    • 3.2.3 Europe Osteoarthritis Market Value by Anatomy Type
    • 3.2.4 Europe Knee Osteoarthritis Market Value
    • 3.2.5 Europe Knee Osteoarthritis Market Value Forecast
  • 3.3 Asia-Pacific
    • 3.3.1 Asia-Pacific Osteoarthritis Market Value
    • 3.3.2 Asia-Pacific Osteoarthritis Market Value Forecast
    • 3.3.3 Asia-Pacific Osteoarthritis Market Value by Anatomy Type
    • 3.3.4 Asia-Pacific Knee Osteoarthritis Market Value
    • 3.3.5 Asia-Pacific Knee Osteoarthritis Market Value Forecast

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Inclining Occurrence of Osteoarthritis
    • 4.1.2 Growing Geriatric Population
    • 4.1.3 Rising Healthcare Expenditure per Capita
    • 4.1.4 Growing Obese Population
    • 4.1.5 Improving Consumer Confidence Index
  • 4.2 Key Trends and Developments
    • 4.2.1 Growth in Pharmaceutical R&D Expenditures
    • 4.2.2 Progressing Product Pipeline
    • 4.2.3 Advancement in Osteoarthritis Treatments
    • 4.2.4 Growth in Online Pharmaceutical Sales
  • 4.3 Challenges
    • 4.3.1 Associated Business Risk
    • 4.3.2 Patient Health-Associated Risk
    • 4.3.3 Stringent Regulations

5. Company Profiles

  • 5.1 Johnson & Johnson
    • 5.1.1 Business Overview
  • 5.2 Novartis AG
    • 5.2.1 Business Overview
  • 5.3 Bayer AG
    • 5.3.1 Business Overview
  • 5.4 GlaxoSmithKline Plc
    • 5.4.1 Business Overview
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
  • 5.6 Sanofi S.A.
    • 5.6.1 Business Overview
Back to Top
전화 문의
F A Q